"A-Share Focus" Staidson BioPharm plummets 8.5%, the third-largest shareholder plans to reduce holdings
I'm PortAI, I can summarize articles.
Pharmaceutical company Staidson BioPharm (Shenzhen: 300204) saw its stock price plummet by 8.5%, currently reported at 34.02 yuan. The company announced that its third-largest shareholder, Xiangtang Group, plans to reduce its holdings by no more than 4.7777 million shares, accounting for 1% of the total share capital. Based on yesterday's closing price, the cash amount that Xiangtang Group will realize is approximately 178 million yuan. Xiangtang Group currently holds 27.1396 million shares, accounting for 5.68% of the total share capital. This year, Staidson's stock price has increased by 361%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: etnet The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments